To determine the robustness of the A/L ratio in predicting the risk of incident CKD in comparison with leptin alone, we conducted an additional analysis comparing the predictive performance of leptin and the A/L ratio (Table S3). The gene discussed is LEP; the disease is chronic kidney disease.